期刊文献+

浅谈甲状腺功能亢进症患者血清抵抗素水平与血糖、血脂及甲状腺激素的关系 被引量:11

Relationship Between Serum Resistin Levels and Blood Glucose,Blood Lipid and Thyroid Hormone in Patients with Hyperthyroidism
下载PDF
导出
摘要 目的对甲状腺功能亢进症患者的血清抵抗素水平与血糖、血脂及甲状腺激素的关系进行分析和探讨。方法选择2013年4月至2014年5月我院收治的60例甲状腺功能亢进患者作为本次研究的实验组,另选择60例健康人员作为本次的对照组。结果实验组患者的空腹血糖高于对照组,T-CH、LDL-C低于对照组(P<0.05);实验组患者的FT3、FT4、胰岛素、抵抗素、HOMA-IR明显高于对照组、TSH明显低于对照组(P<0.05);甲状腺功能亢进症患者的血清抵抗素水平与FT3、FT4、HOMA-IR呈正相关关系,与T-CH、LDL-C呈负相关关系。结论甲状腺功能亢进症患者血清抵抗素水平与血糖、血脂及甲状腺激素有密切的关系。 Objective To explore the relationship between serum resistin levels and blood glucose, blood lipids and thyroid hormone in patients with hyperthyroidism. Methods The serum resistin levels and blood glucose, blood lipids and thyroid hormone in 60 patients with hyperthyroidism and 60 healthy controls were detected. Results The fasting blood glucose concentration in patients with hyperthyroidism was higher than that of controls, but the T- CH and LDL- C levels were less than that of control group ( P 〈 0.05 ). The FT3, FT4, insulin, resistin and HOMA-IR in patients were significantly higher than those in the control group, and TSH was significantly lower than that of the control group (P 〈 0.05 ). The serum resistin levels in patients with hyperthyroidism was positively related with the levels of FT3, FT4 and HOMA-IR, and negatively related with T-CH and LDL-C levels. Conclusion The serum resistin levels in patients with hyperthyroidism are closely related with thyroid hormone, blood lipid and blood glucose.
作者 黄伟 石磊
出处 《标记免疫分析与临床》 CAS 2015年第12期1275-1276,共2页 Labeled Immunoassays and Clinical Medicine
关键词 甲状腺功能亢进 血清抵抗素水平 血糖 血脂 Hyperthyroidism Serum resistin level Blood glucose Blood lipid
  • 相关文献

参考文献5

二级参考文献41

  • 1郝建华,曾飞鹏,冯静霞,张庆侠.甲状腺机能亢进症血脂和总蛋白的变化及意义[J].中国实用内科杂志,2001,21(4):216-217. 被引量:8
  • 2刘瑞春,许蕾,崔满菊.甲状腺机能亢进并发缺血性脑血管病[J].脑与神经疾病杂志,2004,12(4):297-298. 被引量:5
  • 3齐颖,张人玲,华琦.甲状腺功能减退症与亚临床甲状腺功能减退症患者的血脂水平变化[J].实用医学杂志,2006,22(6):670-671. 被引量:14
  • 4李桂凤 韩莹.甲状腺机能亢进患者血清总蛋白测定及临床意义.河北医药,1998,20(6):368-368.
  • 5Ramsay I,Lewis.Thyroid[M].7th ed.Philadelphia:Lippincott Raven Press,1996:687.
  • 6Koemer A,Kratzsch J,Kiess W,et al.Adipocytokines:leptin-the classical,resistin--the controversical,adiponectin-the promising,and more to come[J].Best Pract Res Clin Endocrinol Metab,2005,19(4):525-546.
  • 7Bemdt J,Kl(o)ting N,Kralisch S,et al.Plasma visfatin concentrations and fat depot-specific mRNA expression in humans[J].Diabetes,2005,54(10):2911-2916.
  • 8Fukuhara A,Matsuda M,Nishizawa M,et al.Visfatin:a protein secreted by visceral fat that mimics the effects of insulin[J].Science,2005,307 (5708):426-430.
  • 9Maed N,Takahashi M,Funahashi T,et al.PPARgamma ligands increase expression and plasma concentrations of adiponectin an adipose derived protein[J].Diabetes,2001,50(9):2094-2099.
  • 10Marcus C,Ehren H,Bolme P,et al.Regulation of lipolysis during the neonatal period.Importance of thyrotropin[J].J Clin Invest,1988,82(5):1973-1977.

共引文献27

同被引文献115

引证文献11

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部